Modeling a seeded continuous crystallizer for the production of active pharmaceutical ingredients

被引:35
|
作者
Besenhard, M. O. [1 ,2 ]
Hohl, R. [1 ]
Hodzic, A. [1 ]
Eder, R. J. P. [3 ]
Khinast, J. G. [1 ,3 ]
机构
[1] Res Ctr Pharmaceut Engn RCPE GmbH, A-8010 Graz, Austria
[2] Siemens AG, Corp Technol, A-8054 Graz, Austria
[3] Graz Univ Technol, Inst Proc & Particle Engn, A-8010 Graz, Austria
关键词
continuous crystallization; PBE modeling; sensitivity analysis; aggregation; supersaturation control; POPULATION BALANCE-EQUATIONS; AGGREGATION-BREAKAGE PROCESSES; PREFERENTIAL CRYSTALLIZATION; INDUSTRIAL CRYSTALLIZATION; ACETYLSALICYLIC-ACID; QUADRATURE METHOD; TURBULENT FLUID; PIVOT TECHNIQUE; PRECIPITATION; AGGLOMERATION;
D O I
10.1002/crat.201300305
中图分类号
O7 [晶体学];
学科分类号
0702 ; 070205 ; 0703 ; 080501 ;
摘要
The approximation of a well mixed reactor is prevalent when it comes to the modeling of a crystallization process. Since temperature, concentration, and mass content vary due to inhomogeneous mixing, this approximation is a very loose one. The continuously operated seeded tubular crystallizer system developed in our group overcomes obstacles like a slow response to changes in the outer parameters and inhomogeneous mixing. Therefore the applicable well mixed assumption facilitates detailed modeling of the crystallization process by means of population balance equations (PBE) coupled with mass and energy balances. Modeled results were validated by means of experiments. The amount of aggregation events during the crystallization could be quantified and it was proven that the growth of seeded crystals is almost exclusively responsible for solid mass uptake if the reactor is operated appropriately. The performed sensitivity analysis exposed which process settings should be maintained most accurately to avoid fluctuations in the product crystals' quality attributes and to limit undesired nucleation events.
引用
收藏
页码:92 / 108
页数:17
相关论文
共 50 条
  • [31] Modeling and control of a semi-batch cooling seeded crystallizer
    Rachah, Amira
    Noll, Dominikus
    [J]. 2015 6TH INTERNATIONAL CONFERENCE ON MODELING, SIMULATION, AND APPLIED OPTIMIZATION (ICMSAO), 2015,
  • [33] Active Pharmaceutical Ingredients Transportation and Release from Aerogel Particles Processes Modeling
    Lebedev, Igor
    Uvarova, Anastasia
    Mochalova, Maria
    Menshutina, Natalia
    [J]. COMPUTATION, 2022, 10 (08)
  • [34] Manufacturing peptides as active pharmaceutical ingredients
    Zompra, Aikaterini A.
    Galanis, Athanassios S.
    Werbitzky, Oleg
    Albericio, Fernando
    [J]. FUTURE MEDICINAL CHEMISTRY, 2009, 1 (02) : 361 - 377
  • [35] The revival of cyclodextrins as active pharmaceutical ingredients
    Kfoury, Miriana
    Lichtfouse, Eric
    Fourmentin, Sophie
    [J]. ENVIRONMENTAL CHEMISTRY LETTERS, 2024,
  • [36] Ionic Liquids as Active Pharmaceutical Ingredients
    Ferraz, Ricardo
    Branco, Luis C.
    Prudencio, Cristina
    Noronha, Joao Paulo
    Petrovski, Zeljko
    [J]. CHEMMEDCHEM, 2011, 6 (06) : 975 - 985
  • [37] Active pharmaceutical ingredients are big business
    Stoker, A
    [J]. TCE, 2002, (732): : 38 - 39
  • [38] Modeling fluidized bed impregnation of active pharmaceutical ingredients onto porous excipients
    Grigorov, Plamen, I
    Muzzio, Fernando J.
    Glasser, Benjamin J.
    [J]. CHEMICAL ENGINEERING SCIENCE, 2019, 202 : 36 - 54
  • [39] Digital Design of Filtration and Washing of Active Pharmaceutical Ingredients via Mechanistic Modeling
    Ottoboni, Sara
    Brown, Cameron J.
    Mehta, Bhavik
    Jimeno, Guillermo
    Mitchell, Niall A.
    Sefcik, Jan
    Price, Chris J.
    [J]. ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2022, 26 (12) : 3236 - 3253
  • [40] Precision active pharmaceutical ingredients are the goal
    Miller, Andrew D.
    [J]. FUTURE MEDICINAL CHEMISTRY, 2016, 8 (11) : 1209 - 1238